Frazier Healthcare Partners Launches Recida Therapeutics to Develop Novel Therapeutics for Serious Antibiotic-Resistant Infections
Frazier recently announced the launch of Recida, a biopharma company focused on developing novel therapies for antibiotic-resistant infections